ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.000
-0.040 (-3.85%)
At close: Oct 30, 2026, 4:00 PM EDT
1.027
+0.027 (2.72%)
After-hours: Oct 30, 2026, 7:57 PM EDT
ABVC BioPharma Employees
As of December 31, 2025, ABVC BioPharma had 19 total employees, including 16 full-time and 3 part-time employees. The number of employees did not change compared to the previous year. That makes ABVC BioPharma the 38,536th largest employer in the world and 5,559th in the United States.
Employees
19
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$374,033
Market Cap
25.96M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 19 | 0 | - | 16 | 3 |
| Dec 31, 2024 | 19 | 0 | - | 16 | 3 |
| Dec 31, 2023 | 19 | -4 | -17.39% | 16 | 3 |
| Dec 31, 2022 | 23 | -7 | -23.33% | 19 | 4 |
| Dec 31, 2021 | 30 | -4 | -11.76% | 28 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Metagenomi Therapeutics | 113 |
| Evaxion | 46 |
| NextCure | 40 |
| Aardvark Therapeutics | 28 |
| BriaCell Therapeutics | 16 |
| CervoMed | 15 |
| TransCode Therapeutics | 12 |
ABVC News
- 4 weeks ago - ABVC BioPharma Proxy statement: Proxy filing - Filings
- 7 weeks ago - ABVC BioPharma Proxy statement: Proxy filing - Filings
- 2 months ago - ABVC BioPharma Proxy statement: Proxy filing - Filings
- 2 months ago - ABVC BioPharma Proxy statement: Proxy filing - Filings
- 2 months ago - ABVC BioPharma Quarterly report: Q2 2026 - Filings
- 2 months ago - ABVC Biopharma Inc trading halted, news pending - TheFly
- 3 months ago - ABVC BioPharma Proxy statement: Proxy filing - Filings
- 5 months ago - ABVC BioPharma Quarterly report: Q1 2026 - Filings